https://pubmed.ncbi.nlm.nih.gov/33679717/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1bQr69UjXVaRRUWkFKIzHYhAULOEOHnEnNj24W3oISCxcPMYuA&fc=None&ff=20210308072436&v=2.14.2
TITLE:
Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
DESCRIPTION:
Type 1 diabetes (T1D) is widely considered to be a T cell driven autoimmune disease resulting in reduced insulin production due to dysfunction/destruction of pancreatic β cells. Currently, there continues to be a need for immunotherapies that selectively reestablish persistent β cell-specific self-tolerance for the prevention and remission of T1D in the clinic. The utilization of monoclonal antibodies (mAb) is one strategy to target specific immune cell populations inducing autoimmune-driven…
PMID:
pubmed:33679717
DATE FOUND:
03/08/21 07:35AM
LINK / URL:
https://pubmed.ncbi.nlm.nih.gov/33679717/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1bQr69UjXVaRRUWkFKIzHYhAULOEOHnEnNj24W3oISCxcPMYuA&fc=None&ff=20210308072436&v=2.14.2
